Medicine
Stiolto Respimat 2.736 mcg/3.124 mcg spray
Stiolto Respimat 2.736 mcg/3.124 mcg spray is a prescription medicine containing Olodaterol and Tiotropium for inhalation use, marketed by Boehringer Ingelheim Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Avoid freezing. Store at 20°C to 25°C (68°F to 77°F), excursions permitted to…
Key facts
- Active ingredient (INN)
- Olodaterol and Tiotropium
- Brand
- Stiolto Respimat
- Strength
- 2.736 mcg/3.124 mcg
- Dosage form
- Spray
- Route
- Inhalation
- Packs
- 1 cartridge
- Marketing authorisation holder
- Boehringer Ingelheim Pharmaceuticals
- Manufacturer
- Boehringer Ingelheim Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Avoid freezing. Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 21 May 2015
- Identifiers
- RxCUI 1651266, 1651271, 1651274 +3DailyMed set ID 01e15aee-40e0-23f3-537f-c96dd63e2cb1NDC 0597-0155Application NDA206756
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 cartridge in 1 carton / 28 spray, metered in 1 cartridge | 0597-0155-28 | Boehringer Ingelheim Pharmaceuticals | 21 May 2015 |
| 1 cartridge in 1 carton / 60 spray, metered in 1 cartridge | 0597-0155-61 | Boehringer Ingelheim Pharmaceuticals | 21 May 2015 |
| 1 cartridge in 1 carton / 10 spray, metered in 1 cartridge | 0597-0155-70 | Boehringer Ingelheim Pharmaceuticals | 22 March 2019 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 21 May 2015 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Olodaterol and Tiotropium is a fixed-dose combination of an anticholinergic and a beta2-adrenergic agonist indicated for the long-term, once-daily maintenance treatment of patients with chronic obstructive pulmonary disease (COPD), among other approved uses. MedsAcross supplies Olodaterol and Tiotropium for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Olodaterol and TiotropiumFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Stiolto Respimat prescribing information (Boehringer Ingelheim Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Stiolto Respimat 2.736 mcg/3.124 mcg spray for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.